About
We aim to optimize recognition of genetic tumor risk syndromes and to use tumor-specific genetic aberrations to optimize treatment and monitoring of cancer patients.
Research group leader
prof. dr. Marjolijn Ligtenberg
Research programs
Programs that are connected to this research group.